154 related articles for article (PubMed ID: 26859947)
21. [EXPERIENCE OF USE OF BLEMAREN® IN THE TREATMENT OF PATIENTS IN URIC ACID AND CALCIUM OXALATE UROLITHIASIS].
Konstantinova OV; Yanenko EK
Urologiia; 2015; (5):22-4, 26. PubMed ID: 26859932
[TBL] [Abstract][Full Text] [Related]
22. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
Hess B
Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
[TBL] [Abstract][Full Text] [Related]
23. Alkaline citrate in prevention of recurrent calcium oxalate stones.
Berg C
Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
[TBL] [Abstract][Full Text] [Related]
24. Hyperuricosuric calcium urolithiasis.
Moe OW; Xu LHR
J Nephrol; 2018 Apr; 31(2):189-196. PubMed ID: 29368300
[TBL] [Abstract][Full Text] [Related]
25. Insulin resistance and low urinary citrate excretion in calcium stone formers.
Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
[TBL] [Abstract][Full Text] [Related]
26. Correspondence between Ca²⁺ and calciuria, citrate level and pH of urine in pediatric urolithiasis.
Porowski T; Kirejczyk JK; Konstantynowicz J; Kazberuk A; Plonski G; Wasilewska A; Laube N
Pediatr Nephrol; 2013 Jul; 28(7):1079-84. PubMed ID: 23377289
[TBL] [Abstract][Full Text] [Related]
27. Comparison of biochemistry and diet in patients with enterocystoplasty who do and do not form stones.
Hamid R; Robertson WG; Woodhouse CR
BJU Int; 2008 Jun; 101(11):1427-32. PubMed ID: 18284409
[TBL] [Abstract][Full Text] [Related]
28. Metabolic risk factors and the effect of metaphylaxis in pediatric stone disease with hypocitraturia.
Karsli O; Izol V; Aridogan IA; Borekoglu A; Satar N
Urolithiasis; 2013 Feb; 41(1):9-13. PubMed ID: 23532417
[TBL] [Abstract][Full Text] [Related]
29. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
Hassani MA; Hennequin C; Lacour B; Daudon M
Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
[TBL] [Abstract][Full Text] [Related]
30. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
Laube N; Jansen B; Hesse A
Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
[TBL] [Abstract][Full Text] [Related]
31. [Citrate and renal stones].
del Valle EE; Spivacow FR; Negri AL
Medicina (B Aires); 2013; 73(4):363-8. PubMed ID: 23924538
[TBL] [Abstract][Full Text] [Related]
32. Twenty four hours urine and serum biochemical parameters in patients with urolithiasis.
Jawalekar S; Surve VT; Bhutey AK
Nepal Med Coll J; 2010 Mar; 12(1):5-7. PubMed ID: 20677601
[TBL] [Abstract][Full Text] [Related]
33. Determinants of urolithiasis in patients with intestinal fat malabsorption.
Siener R; Petzold J; Bitterlich N; Alteheld B; Metzner C
Urology; 2013 Jan; 81(1):17-24. PubMed ID: 23200965
[TBL] [Abstract][Full Text] [Related]
34. Citrate and recurrent idiopathic calcium urolithiasis. A longitudinal pilot study on the metabolic effects of oral potassium sodium citrate administered as short-, medium- and long-term to male stone patients.
Herrmann U; Schwille PO; Schwarzlaender H; Berger I; Hoffmann G
Urol Res; 1992; 20(5):347-53. PubMed ID: 1455567
[TBL] [Abstract][Full Text] [Related]
35. Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization.
Siener R; Jahnen A; Hesse A
Eur J Clin Nutr; 2004 Feb; 58(2):270-6. PubMed ID: 14749747
[TBL] [Abstract][Full Text] [Related]
36. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid in the management of hypercalciuric stone formers.
Ortiz-Alvarado O; Miyaoka R; Kriedberg C; Leavitt DA; Moeding A; Stessman M; Monga M
Urology; 2012 Feb; 79(2):282-6. PubMed ID: 22000931
[TBL] [Abstract][Full Text] [Related]
37. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
[TBL] [Abstract][Full Text] [Related]
38. Acute effects of calcium sodium citrate supplementation of a test meal on mineral homeostasis, oxalate, and calcium oxalate crystallization in the urine of healthy humans--preliminary results in patients with idiopathic calcium urolithiasis.
Herrmann U; Schwille PO; Schmiedl A; Fan J; Manoharan M
Biomed Pharmacother; 1999 Jun; 53(5-6):264-73. PubMed ID: 10424248
[TBL] [Abstract][Full Text] [Related]
39. Risk factors associated with calcium oxalate urolithiasis in dogs evaluated at general care veterinary hospitals in the United States.
Okafor CC; Lefebvre SL; Pearl DL; Yang M; Wang M; Blois SL; Lund EM; Dewey CE
Prev Vet Med; 2014 Aug; 115(3-4):217-28. PubMed ID: 24834804
[TBL] [Abstract][Full Text] [Related]
40. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
